A
80R
vs
D
DAX Index
Over the past 12 months, 80R has underperformed DAX Index, delivering a return of -55% compared to the DAX Index's +3% growth.
Stocks Performance
80R vs DAX Index
Performance Gap
80R vs DAX Index
Performance By Year
80R vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
AroCell AB (publ)
Glance View
AroCell AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2011-05-25. The firm's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.
